FOCAL NODULAR HYPERPLASIA

This adverse event was reported 520 times

FOCAL NODULAR HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLINDAMYCIN PHOSPHATE AND TRETINOIN 1 0.0065
1 TRASTUZUMAB-QYYP 1 0.0026
2 THIOTEPA 25 0.0026
3 CHOLIC ACID 1 0.0025
4 LONCASTUXIMAB TESIRINE 1 0.0024
5 NITISINONE 2 0.0021
6 PENICILLIN V POTASSIUM 5 0.0019
7 ESTRADIOL CYPIONATE 1 0.0017
8 SOYBEAN OIL 1 0.0015
9 CANAKINUMAB 16 0.0015
See all drugs enriched for association with FOCAL NODULAR HYPERPLASIA